Dr. Reddy’s Laboratories faced USFDA scrutiny at its New York API facility, receiving a Form 483 with two observations after a GMP inspection concluded on May 16, 2025. The company will address these concerns within the given timeframe. Post navigation SBI में FD कराने पर अब कम ब्याज मिलेगा:1 साल की FD पर 6.50% ब्याज, यहां देखें नई इंटरेस्ट रेट्स RITES eyes revenue growth through export focus, quality assurance & business diversification: CMD
